{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T10:55:59Z","timestamp":1794480959644,"version":"4.9.1"},"reference-count":33,"publisher":"Informa UK Limited","issue":"12","license":[{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Xenobiotica"],"published-print":{"date-parts":[[2022,12,2]]},"DOI":"10.1080\/00498254.2023.2169207","type":"journal-article","created":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T18:22:53Z","timestamp":1674757373000},"page":"1020-1030","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":8,"title":["Human pharmacokinetics prediction with an <i>in\u00a0vitro<\/i>\u2013<i>in\u00a0vivo<\/i> correction factor approach and <i>in\u00a0vitro<\/i> drug-drug interaction profile of bictegravir, a potent integrase-strand transfer inhibitor component in approved biktarvy<sup>\u00ae<\/sup> for the treatment of HIV-1 infection"],"prefix":"10.1080","volume":"52","author":[{"given":"Raju","family":"Subramanian","sequence":"first","affiliation":[{"name":"Gilead Sciences, Inc, Foster City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhong","family":"Wang","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc, Foster City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Murray","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc, Foster City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Custodio","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc, Foster City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Hao","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc, Foster City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Lazerwith","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc, Foster City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"MacLennan Staiger","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc, Foster City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Mwangi","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc, Foster City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailing","family":"Sun","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc, Foster City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Tang","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc, Foster City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Wang","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc, Foster City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerry","family":"Rhodes","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc, Foster City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Wijaya","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc, Foster City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Zhang","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc, Foster City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bill J.","family":"Smith","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc, Foster City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,1,26]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1002\/jps.23235"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1002\/bdd.1769"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(18)30091-2"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.113.053322"},{"key":"CIT0005","unstructured":"[EMA] European Medicines Agency 2018. Public assessment report Biktarvy\u00ae. https:\/\/www.ema.europa.eu\/documents\/assessment-report\/biktarvy-epar-public-assessment-report_en.pdf"},{"key":"CIT0006","unstructured":"European AIDS Clinical Society 2021. Guidelines, version 11.0. https:\/\/www.eacsociety.org\/media\/final2021eacsguidelinesv11.0_oct2021.pdf"},{"key":"CIT0007","unstructured":"[FDA] Food and Drug Administration 2018. Biktarvy\u00ae (bictegravir, emtricitabine, and tenofovir alafenamide) tablets, for oral use. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/210251s000lbl.pdf"},{"issue":"5","key":"CIT0008","first-page":"560","volume":"28","author":"Fisher MB","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32299-7"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1021\/mp300476z"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2014.934671"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1007\/BF01059340"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1002\/jps.22553"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-013-0030-6"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199936030-00003"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-008-9025-8"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1021\/jm0100990"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1177\/0091270003254631"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(18)30092-4"},{"key":"CIT0021","first-page":"46","volume":"283","author":"Obach RS","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"issue":"11","key":"CIT0022","first-page":"1350","volume":"27","author":"Obach RS.","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"CIT0023","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. 2021. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Department of Health and Human Services. http:\/\/www.aidsinfo.nih.gov\/ContentFiles\/AdultandAdolescentGL.pdf"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1002\/jps.22550"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1002\/jps.22552"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.106027"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(17)30016-4"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32340-1"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-018-0420-7"},{"key":"CIT0030","first-page":"1","author":"Subramanian R","year":"2023","journal-title":"Xenobiotica"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01474-16"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2013.09.018"},{"issue":"1","key":"CIT0035","first-page":"A74","volume":"93","author":"Zhang H","year":"2017","journal-title":"Sex Transm Infect"},{"key":"CIT0036","unstructured":"Zhang H, West SK, Vu A, Martin H, Graham H, Quirk E, Kearney BP, Custodio JM. 2017. Lack of Clinically Relevant Effect of Bictegravir on Metformin Pharmacokinetics and Pharmacodynamics. Poster session Presented at: 18th International Workshop on Antiviral Therapy; Chicago, IL."}],"container-title":["Xenobiotica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/00498254.2023.2169207","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T09:36:25Z","timestamp":1676453785000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/00498254.2023.2169207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,2]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12,2]]}},"alternative-id":["10.1080\/00498254.2023.2169207"],"URL":"https:\/\/doi.org\/10.1080\/00498254.2023.2169207","relation":{},"ISSN":["0049-8254","1366-5928"],"issn-type":[{"value":"0049-8254","type":"print"},{"value":"1366-5928","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ixen20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ixen20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-10-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-11","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}